Literature DB >> 4360056

Proceedings: Immunotherapy of malignant disease: the use of viable sensitized lymphocytes or transfer factor prepared from sensitized lymphocytes.

E T Krementz, P W Mansell, M O Hornung, M S Samuels, C A Sutherland, E N Benes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4360056     DOI： 10.1002/1097-0142(197402)33:2<394::aid-cncr2820330214>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  6 in total

Review 1.  Clinical applications of the continuous flow blood separator machine.

Authors:  C J Oon; J R Hobbs
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

2.  Melanoma of the head and neck.

Authors:  M N Harris; D F Roses; A T Culliford; S L Gumport
Journal:  Ann Surg       Date:  1975-07       Impact factor: 12.969

3.  Transfer factor: a potential agent for immunotherapy of cancer.

Authors:  C R Meier; A F LoBuglio
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

Review 4.  The role of immunotherapy in the management of patients with malignant melanoma.

Authors:  J E Goodnight; D L Morton
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

5.  Specific cancer immunotherapy adjunctive to surgery for advanced gastric cancer: a report of six long term survivors.

Authors:  Y Ishikawa; M Fukushima; S Machida; H Kakuta; T Nishikawa; S Fukuda
Journal:  Gastroenterol Jpn       Date:  1978

6.  Immunotherapy as an adjunct to surgery in the treatment of cancer.

Authors:  F R Eilber; E C Holmes; D L Morton
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.